calcium chloride
- Product NDC
- 72658-1879
- 11-digit product format
- 726581879
- Labeler code
- 72658
- Product ID
- 72658-1879_5b0baf5c-9c42-fe55-e063-6294a90a591a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- calcium chloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Eskayef Pharmaceuticals Limited
- Application
- ANDA217463
- Marketing category
- ANDA
- Marketing start
- 2026-09-10
- Substance
- CALCIUM CHLORIDE
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217463-001 | CALCIUM CHLORIDE 10% | CALCIUM CHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2025-09-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217463-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217463-001 | CALCIUM CHLORIDE 10% | 100MG/ML | INJECTABLE / INJECTION | AP | 2025-09-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217463-001 | CALCIUM CHLORIDE 10% | 100MG/ML | INJECTABLE / INJECTION | AP | 2025-09-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217463-001 | CALCIUM CHLORIDE 10% | 100MG/ML | INJECTABLE / INJECTION | AP | 2025-09-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217463-001 | CALCIUM CHLORIDE 10% | 100MG/ML | INJECTABLE / INJECTION | AP | 2025-09-29 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217463-001 | CALCIUM CHLORIDE 10% | 100MG/ML | INJECTABLE / INJECTION | AP | 2025-09-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217463-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217463-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217463-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217463-001 | AP | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217463-001 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- calcium chloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CALCIUM CHLORIDE | 100 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| M4I0D6VV5M | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 828525 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5b0bd762-4c87-597e-e063-6394a90a8303 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| calcium chloride | CALCIUM CHLORIDE | Eskayef Pharmaceuticals Limited | 5b0bd762-4c87-597e-e063-6394a90a8303 | 2026-09-09 | Warnings, Adverse reactions | 217463 ANDA217463 72658-1879 |
| calcium chloride | CALCIUM CHLORIDE | PAI Holdings, LLC dba PAI Pharma | d5d9c301-599e-47bb-ba9b-c0065c08dfb4 | 2026-04-30 | Warnings, Adverse reactions | 217463 ANDA217463 |
| calcium chloride | CALCIUM CHLORIDE | SQUARE PHARMACEUTICALS PLC. | 753c3973-6522-4d33-811b-b63a4e8cc585 | 2026-01-14 | Warnings, Adverse reactions | 217463 ANDA217463 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72658-1879-2 | 72658187902 | 10 VIAL in 1 BOX (72658-1879-2) / 10 mL in 1 VIAL (72658-1879-1) | 10 vial | 2026-09-10 | No | No | Current |